Search

Your search keyword '"Jean Christophe Plantier"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Jean Christophe Plantier" Remove constraint Author: "Jean Christophe Plantier" Publisher hal ccsd Remove constraint Publisher: hal ccsd
33 results on '"Jean Christophe Plantier"'

Search Results

1. Early phylodynamics analysis of the COVID-19 epidemic in France

2. New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

3. Evaluation of four commercial extraction-quantification systems to monitor EBV or CMV viral load in whole blood

4. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure

5. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains

6. Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

7. Short Communication: Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient

8. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

9. Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

10. Detection of numerous HIV-1/MO recombinants in France

11. HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats

12. Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies

13. Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates

14. Multi-site clinical evaluation of the Xpert® HIV-1 viral load assay

15. Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients

16. A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants

17. Infections à virus respiratoire syncytial (VRS) au CHU pédiatrique Charles de Gaulle de Ouagadougou, Burkina Faso

18. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

19. Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants

20. First report of transmission of a highly resistant strain of HIV-1 group O

21. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants

22. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

23. First evidence of transmission of an HIV-1 M/O intergroup recombinant virus

24. Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy

25. Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping

26. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study

27. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study

28. Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients

29. HIV-1/MO intergroup recombinant forms : study of their replicative potential and their emergence in vitro/in vivo

30. Infection par le VIH-1 groupe O : étude des caractéristiques épidémiologiques et de la réponse immuno-virologique aux antirétroviraux

31. Variants non-M du VIH-1 : Sensibilité naturelle aux inhibiteurs d'intégrase et d'attachement, réponses immunologique et virologique des patients aux antirétroviraux

32. HIV-1 group O infection : the study of the epidemiological characteristic of this infection and the immune-virological response to ART

33. Non-group M HIV-1 : Natural susceptibility to integrase and attachment inhibitors, Immunologic and virologic response of infected patients to antiretrovirals

Catalog

Books, media, physical & digital resources